Executive Series Reception with CIRM and Geron Executives
The BayBio Board of Directors invites you to attend a reception for Northern California C Suite Executives. No boring speeches, no official program – just an opportunity to connect with fellow life sciences executives and to have a glass of wine in a relaxed atmosphere. This will be a perfect opportunity to meet with David L. Greenwood, President and CEO of Geron Corporation, and Jonathan Thomas, Ph.D., J.D., Board Chair, chairman of the California Institute for Regenerative Medicine (CIRM).
Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases. The company is advancing anti- cancer therapies through multiple Phase 2 clinical trials in different cancers by targeting the enzyme telomerase and with a compound designed to penetrate the blood-brain barrier. The company is developing cell therapy products from differentiated human embryonic stem cells for multiple indications, including central nervous system (CNS) disorders, heart failure, diabetes and osteoarthritis, and has initiated a Phase 1 clinical trial in spinal cord injury.
The California Institute for Regenerative Medicine is accelerating the development of new therapies for chronic disease and injury by funding stem cell research programs throughout California. We were established in 2004 after Californians passed Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities. The mission of CIRM is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury.
Open to C Suite Executives of Life Sciences Companies Only.
|What:||Executive Series Reception with CIRM and Geron Executives:
Jonathan Thomas, Ph.D., J.D.
David L. Greenwood
|When:||Thursday, September 8, 2011
|Where:||Provided upon RSVP|
|Parking:||Multiple Public Parking Options Available in Immediate Area|
|Attendance:||RSVP by September 7th is required
No On-Site Registration.
Open to C-Suite Executives of Life Sciences Companies Only.
|Cost:||BayBio Members – Complimentary
Non-Members – $75.00